🇺🇸 FDA
Patent

US 9211323

Compositions and methods for administration of vaccines against dengue virus

granted A61KA61K2039/5254A61K2039/54

Quick answer

US patent 9211323 (Compositions and methods for administration of vaccines against dengue virus) held by Takeda Vaccines, Inc. expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/5254, A61K2039/54, A61K2039/545, A61K2039/70